Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Currency in USD	2025
Operating Income	118.37 Million
Income Before Tax	24.55 Million
Income Tax Expense	-33.98 Million
Net Income	-905.64 Million
Eps	-20.30
Epsdiluted	-20.25
Weighted Average Shs Out	44.62 Million
Weighted Average Shs Out Dil	44.72 Million
Research And Development Expenses	144.78 Million
Selling General And Administrative Expenses	720.17 Million
Depreciation And Amortization	177.74 Million
Interest Expense	100.22 Million
Interest Income	6.40 Million
Net Interest Income	-93.82 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	1.12 Billion
Ebitda	433.54 Million
Source	edgar
Ebit	124.78 Million

Teleflex Incorporated Annual Reports (10-K)